Ayurvedic Treatment of Leukemia in Mumbai
Ayurvedic treatment for leukemia in Mumbai offers a holistic approach, combining traditional remedies with modern medical techniques. Renowned Ayurvedic centers in Mumbai provide personalized treatment plans tailored to individual needs, focusing on enhancing immunity, detoxification, and rejuvenation. With a blend of herbal medicines, dietary modifications, lifestyle adjustments, and therapeutic practices, Ayurveda aims to address the root cause of the disease and promote overall well-being. Seek expert guidance from experienced Ayurvedic practitioners in Mumbai to explore natural remedies alongside conventional treatments for managing leukemia or blood cancer effectively.
About ‘Ayurveda’
Ayurveda is a traditional system of medicine that originated in India 3000 years ago. Ayurveda is derived from two words in Sanskrit “Ayur” and “Veda”. “Ayur” means life and “Veda” means knowledge and science. So, Ayurveda means science that refers to art of living or life.
Key principles of Ayurveda include:
1) Doshas: Ayurveda defines three fundamental bodily energies or doshas – 1) Vata 2) Pitta, and 3) Kapha. This bodily energies or doshas govern and regulate various physiological and psychological aspect of an individual. Doshas plays an important aspect in maintaining physical and mental well-being of an individual, and every individual is unique in terms of combination of doshas.
2) Dhatus: As per Ayurveda, an individual is composed of seven fundamental tissues or known as Dhatus in Ayurveda. The seven dhatus are 1) Rasa 2) Raktha 3) Mansa 4) Meda 5) Asthi 6) Majja, and 7) Sukhra.
3) Prakriti: Prakriti is defined as an individual inherent constitution of predominant doshas in the body. This “Prakriti” is formed during fertilization of the sperm and ovum, and helps in tailoring various lifestyle, diet, and therapeutic aspects of an individual.
4) Agni: Agni in general terms is defined as digestive power of an individual and is important to assimilate the food. Agni in balanced state is important for proper digestion and health of an individual.
What is myeloid tissue?
Myeloid tissue is a type of hematopoietic tissue, and it produces different type of blood cells. Myeloid tissue is primarily located in spleen and liver in the fetal stage of an individual, and later the hematopoietic tissue migrates to bone marrow and start producing blood cells. Myeloid tissue produces different types of blood cells:
What is Leukemia?
Leukemia is a type of cancer of the blood that primarily affects the blood cells, and the bone marrow too. Leukemia originates in the bone marrow, and there is abnormal increase in the number of white blood cells. These white blood cells do not mature properly and are unable to function8.
So, leukemia can be called abnormal and large number of immature white blood cells. These immature white blood cells compete with their normal counterparts or healthy white blood cells, and outperform them, leading to various complications. It is well known fact that white blood cells plays important role in immune function, and in leukemia due to abundance of immature cells immune function is also compromised.
There are different types of leukemia, and are classified based on the type of blood cells affected: 1) Lymphoid Cells. 2) Myeloid Cells. It is also differentiated based on the rate of the progression of the disease: 1) Acute. 2) Chronic. So, acute leukemia is a white blood cell disease that progresses rapidly and chronic leukemia is white blood cell disease that progresses slowly.
Types of Leukemia
Leukemia is majorly classified into four main types, and the classification principles is based on type of blood cell involved in leukemia and rate of progression of leukemia.
1) Acute Lymphoblastic Leukemia (ALL):
Acute Lymphoblastic Leukemia (ALL) is a type of leukemia that is characterized by rapid and abnormal proliferation of immature lymphoid tissue or lymphoblast’s. Acute Lymphoblastic Leukemia (ALL) is more common in children and adults are affected too. Types of Acute Lymphoblastic Leukemia (ALL) are:
- B – Cell Acute Lymphoblastic Leukemia (ALL): This subtype involves immature B-Cell Lymphocyte, and is most common in children’s as well as adults.
- T-cell Acute Lymphoblastic Leukemia (ALL): This subtype involves abnormal proliferation and growth of T-Cell Lymphocyte, and is less common than B-Cell Lymphoma. T-cell Acute Lymphoblastic Leukemia (ALL) most commonly affects adolescents and adults.
- Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL): Philadelphia Chromosome-positive ALL has a specific genetic abnormality known as Philadelphia chromosome. Philadelphia chromosome is most commonly found in Chronic Myeloid Leukemia (CML) but is also found in certain subtype of ALL.
- Mixed Phenotype Acute Leukemia (MPAL): Cells involved in Mixed Phenotype Acute Leukemia (MPAL) have characteristics of both lymphoblast’s and myoblasts.
2) Chronic Lymphocytic Leukemia (CLL):
Chronic Lymphocytic Leukemia (CLL) is characterized by rapid and abnormal growth of mature lymphocytes. It is more common in older adults and can be asymptomatic at earlier stages. Types of Chronic Lymphocytic Leukemia (CLL) are:
- IgVH Mutational Status: In this type of Chronic Lymphocytic Leukemia the leukemia cells may have mutations in the immunoglobulin heavy chain variable region (IgVH). The mutations status of the immunoglobulin heavy chain variable region (IgVH) may influence the prognosis and treatment status of the leukemia.
- ZAP – 70 and CD38 Expression: In this type of Chronic Lymphocytic Leukemia the leukemia cells may express protein such as ZAP-70 and CD 38. The mutational status of the proteins can determine the aggressiveness of the leukemia.
- Del (17p) and Del (11q): In this type of Chronic Lymphocytic Leukemia the leukemia cells may have deletions in the short arm of chromosome 17 or long arm of the chromosome 11. These mutation status of the chromosome 17 or 19 may affect the prognosis and the treatment status of the leukemia.
- TP53 Mutation: In this type of Chronic Lymphocytic Leukemia, the leukemia cells have mutations in the TP53 gene. The mutations in the TP53 gene conveys more aggressiveness to the leukemia.
- Richter Transformation: In this type of Chronic Lymphocytic Leukemia, a small percentage of the leukemia can transfer into more aggressive form of lymphoma and it is called Richter transformation.
- Complex Karyotype: Some cases of Chronic Lymphocytic Leukemia (CLL) have multiple chromosomal abnormalities, and confers poor prognosis and disease progression to the leukemia.
3) Acute Myeloid Leukemia (AML):
Acute Myeloid Leukemia (AML) is characterized by rapid and abnormal growth of myeloid cells in the bone marrow. Myeloid cells acquires mutations, and develops ability of sustained proliferation and evading apoptosis. AML can occurs in both children and adults. Types of Acute Myeloid Leukemia (AML) as follows:
- Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities: This subtype of Acute Myeloid Leukemia (AML) acquires specific genetic abnormalities. These specific genetic abnormalities displays distinct clinical symptoms and have different treatment protocols. Examples of these genetic abnormalities are t(8;21), inv(16), t(16;16), and others.
- Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes: Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes may develops from pre-existing myelodysplastic syndrome or other myeloproliferative neoplasms. This subtype of Acute Myeloid Leukemia (AML) is classified on the degree of dysplasia and harbors specific genetic abnormalities.
- Therapy-Related Acute Myeloid Leukemia (t-AML): Therapy-Related Acute Myeloid Leukemia (t-AML) develops due to chemotherapy or radiotherapy which has been administered for other types of cancers. Therapy-Related Acute Myeloid Leukemia (t-AML) confers poor prognosis and is associated with specific genetic mutations.
- Acute Myeloid Leukemia (AML) Not Otherwise Specified (NOS): Acute Myeloid Leukemia (AML) Not Otherwise Specified (NOS) is a subtype of leukemia that does not fits into other defined subtypes. This subtype of AML have distinct clinical features and genetic abnormalities.
- Acute Promyelocytic Leukemia (APL): Acute Promyelocytic Leukemia (APL) is specific subtype of AML and is characterized by a distinct translocation t(15;17). This translocation leads to formation of PML-RARA fusion gene. Acute Promyelocytic Leukemia (APL) is a distinct subtype of Leukemia responds to ATRA (all-trans retinoic acid) and ATO (Arsenic Tri-Oxide).
- AML with FLT3 Mutations: AML with FLT3 Mutations is a distinct subtype of Leukemia and generally confers poor prognosis.
- AML with NPM1 Mutation: AML with NPM1 Mutation is a distinct subtype of Leukemia and generally confers favorable prognosis.
4) Chronic Myeloid Leukemia (CML):
Chronic Myeloid Leukemia (CML) is characterized by excessive proliferation and abnormal growth of mature myeloid cells. CML generally progress slowly and has distinct BCR-ABL fusion gene. Chronic Myeloid Leukemia (CML) statistically happens in adults and has Philadelphia chromosome.
Leukemia Statistics
Leukemia is type of cancer that originates, and affects blood and the bone marrow. Leukemia is caused by abnormal and sustained proliferation of blood cells due to genetic mutation which can be acquired or can be hereditary. This abnormal growth of the blood cells in leukemia is monoclonal expansion and its overcrowding affects healthy bone marrow cells. When healthy stem cells are affected it can lead to anemia, infection, and bleeding issues too. The statistics Leukemia as follows:
1) In 2020, it is estimated that globally 476,000 new cases of leukemia was registered and 314,000 deaths can be attributed to leukemia.
2) Most common type of leukemia is Acute lymphoblastic leukemia (24%), and the least commonest type of leukemia is Chronic myelomonocytic leukemia (CMML) (1%).
3) In India in 2020, it is estimated that 103,000 new cases of leukemia was registered and 70,000 deaths can be attributed to leukemia in India.
4) In India, most common type of leukemia is Acute lymphoblastic leukemia (ALL) (45%), and the least common type of leukemia is Chronic lymphocytic leukemia (CLL) (7%).
5) Leukemia is the most common type of cancer in childhood, and over 60% of cancer in childhood in India can be attributed to Leukemia. In adults, leukemia is also a common type of cancer and its incidence increases as the age progresses.
6) Survival rates due to cancer in India is lower as compared to developed countries and it can be owed to limited healthcare facilities.
Symptoms of Leukemia
Leukemia symptoms vary widely across patients, and it even depends on the stage and types of leukemia the patient is suffering from. Some general symptoms of leukemia or blood cancer are:
1) Fatigue: Complaining of unexplained persistent tiredness or weakness is one of the common symptoms of leukemia. It does not resolve even after rest or sleep.
2) Unexplained weight loss: Complaining of unexplained weight loss (more than 10% of actual weight), even after not trying to do so.
3) Frequent Infections: Leukemic cells expands in numbers and hinders the normal function of the white blood cells thereby increasing the risk of the frequent infections and morbidity.
4) Fever and Night Sweats: Leukemia may be evident by persistent and recurrent fever. Leukemia may also display symptoms of night sweat.
5) Swollen Lymph Nodes: In leukemia, swollen lymph nodes may be evident in the neck and groin region.
6) Anemia: Leukemic patients can develop pale skin or anemia because of less production of RBC’s due to improper functioning of the bone marrow.
It is important to note that all the above mentioned symptoms could be present in wide range of diseases, so it is important to consult a health care provider.
Etiological factors of Leukemia
Leukemia is a multifactorial and a complex disorders roughly designated as blood cancer. There are multiple subtypes in blood cancer or leukemia, and it exact ca,use is yet not well understood or known. There are few known and recognized etiological factors associated with the development of leukemia and the same is described further:
1) Genetic Factors: Inherited genetic abnormalities can predispose an individuals to leukemia or blood cancer. Certain known genetic abnormalities or mutations like Down’s Syndrome etc. predisposes or increase an individual risk to develop leukemia or blood cancer.
2) Radiation Exposure: High dosage of ionizing radiation from medical treatments like radiation therapy or CT Scan, and or from environmental sources like nuclear exposure. is known to elevate the risk of leukemia or blood cancer.
3) Chemical Exposure: Exposure to certain chemicals like benzene, chemotherapeutic drugs which has been administered for treatment of another cancer etc. predisposes to the risk of development of leukemia or cancer.
4) Immune System Disorders: Certain predisposing conditions that effects the immune system like autoimmune disorders or inherited immunodeficiency disorders may contribute or elevates the risk of leukemia or blood cancer.
5) Viral Infections: Certain viral infections Human T-Cell Leukemia Virus (HTLV-1) and Epstein – Barr virus (EBV) is associated with increased risk or predisposition to certain types of leukemia or blood cancer.
It is important to note that having inherited certain genetic mutations doesn’t warrants that a person will certainly develop a cancer, but an additional periodic and regular screenings is required to detect the cancer at an early stage and help to mitigate the risk.
Treatment of Leukemia
The treatment of leukemia varies, and depends on multiple factors and specific type of leukemia which is being treated. Treatment of the leukemia also depends on the patient’s age, and his overall general health statistics or condition. Here are some common treatment modalities for leukemia or blood cancer:
1) Chemotherapy.
2) Targeted Therapy
3) Targeted Therapy
4) Stem Cell Transplant: a) Autologous Stem Cell Transplant. b) Allogeneic Stem Cell Transplant.
5) Immunotherapy
6) Biological Therapy
It is important to note that treatment of leukemia or blood cancer is of multidisciplinary approach, and requires meticulous planning while taking in consideration multiple factors comprising patient’s age, overall health, financial conditions and presence of specific genetic mutations. The choice of treatment now even takes into account patients choices and its potential benefits, and drawbacks.
Leukemia or Blood Cancer in Ayurveda/ आयुर्वेद में ल्यूकेमिया या खून का कैंसर
In Ayurveda texts, no such specific term designating leukemia or blood cancer is mentioned or described, but its ‘Dosha Samprapti or Etiopathology’ can be compared with the topic or roga called ‘Vishama Jwara/ विषम ज्वर’. When the same dosha and dushya samprapti as mentioned in Vishama Jwara/ विषम ज्वर resides in Majja dhatu (मज्जा धातु) or Bone marrow it is called ‘Leukemia or ल्यूकेमिया’.
Under category of Vishama Jwara/ विषम ज्वर, 5 different types of ज्वर/Jwara is mentioned: 1) Santata Jwara. 2) Satata Jwara. 3) Anyedyushka Jwara. 4) Tritiyaka Jwara. 5) Chaturthaka Jwara.
1) Santata Jwara: In santata jwara vitiated or aggravated doshas circulate through rasavaha strotas and spread all over the body, and causes santata jwara. By nature of the disease santata jwara is extremely difficult to treat, and shows its symptoms very quickly.
2) Satata Jwara: In satata jwara vitiated or aggravated doshas circulate through rakthavaha strotas and spread all over the body, and further cause’s satata jwara. Satata Jwara manifests twice in 24 hours.
3) Anyedyushka Jwara: Anyedyushka Jwara vitiated or aggravated doshas circulate through medovaha strotas and spread all over the body, and further cause’s anyedyushka jwara. Anyedyushka Jwara manifests only once during day and night.
4) Tritiyaka Jwara: Tritiyaka Jwara vitiated or aggravated doshas circulate through asthivaha strotas and spread all over the body, and further cause’s tritiyaka jwara. Tritiyaka jwara fever manifest after a gap of one day.
5) Chaturthaka Jwara: Chaturthaka Jwara vitiated or aggravated doshas circulate through majjavaha strotas and spread all over the body, and further cause’s chaturthaka jwara. Chaturthaka jwara fever manifest after a gap of two days.
Concept of Majja dhatu (मज्जा धातु), and its relationship in Etiopathology or Samprapti of Leukemia or Blood Cancer
Majja dhatu (मज्जा धातु)
करोति तत्र सौषिर्यमस्थ्नां मध्ये समीरणः||मेदसस्तानि पूर्यन्ते स्नेहो मज्जा ततः स्मृतः| Charak Chikitsasthana 15/32
Majja Dhatu is formed when vata dhatu creates hollowness in the asthi dhatu and later this hollow cavity is filled by fatty tissue called Majja dhatu (मज्जा धातु).
Majjavaha Strotas (मज्जावह स्रोतस)
मज्जवहानां स्रोतसामस्थीनि मूलं सन्धयश्च| Charak Vimansthana 5/8
Majjavaha Strotas originates in bones and joints.
Causes of vitiation of Majjavaha Strotas (मज्जावह स्रोतस)
उत्पेषादत्यभिष्यन्दादभिघातात् प्रपीडनात्| मज्जवाहीनि दुष्यन्ति विरुद्धानां च सेवनात्|| Charaka Vimanasthana 5/18
Majjavaha Strotas is vitiated due to crushing injury, excessive discharge, trauma due to compression and repeated consumption of incompatible or virrudha ahara (foods).
Symptoms of vitiation of Majja Dhatu
रुक् पर्वणां भ्रमो मूर्च्छा दर्शनं तमसस्तथा| अरुषां स्थूलमूलानां पर्वजानां च दर्शनम्|| मज्जप्रदोषात्| Charak Vimanasthana 28/18
Symptoms of vitiation of majja dhatu is pain in the joints, unconsciousness, giddiness, blackouts, and abscess in the joints.
Management of vitiation of Majja Dhatu
मज्जशुक्रसमुत्थानामौषधं स्वादुतिक्तकम्| अन्नं व्यवायव्यायामौ शुद्धिः काले च मात्रया|| Charak Sutrasthana 28/18
Majja Dhatu disorders is treated with diet which is having sweet and bitter taste, exercise, and timely mental and physical purification (Panchakarma Therapy).
The critical concept of Majjadhara Kala and Pittadhara Kala
एवमा येव पित्तधरा सेव मज्जाधरैति|
As per Ayurveda, there is a relationship between Majjadhara Kala and Pittadhara Kala. And this relationship has been established in ‘Vishavega’ topic. So different factors which causes dusthi of Agni also causes various diseases of Pittadhara Kala and Majjadhara Kala, and so the treatment principles.
Ayurvedic treatment for leukemia in Mumbai
The main goal of Ayurveda therapy is to find the cause of the Leukemia, while the therapeutic approach of Ayurveda is simply divided into two major categories:
1) Oral medications.
2) Panchakarma.
Oral medications
1) Suvarna Vasant Malini Rasa (सुवर्ण मालिनी वसंत) in Leukemia or Blood Cancer Patients
As mentioned in Ayurveda, Suvarana Malini Vasant is a herbo-mineral formulation with major ingredient as Suvarna Bhasma (gold), and traditionally has many health benefits. The ingredients of Suvarna Malini Vasant is Suvarna Bhasma, Mukhta Bhasma, Darada, Maricha, Kharpara, Parada, Gandhaka, Vyosha, Tamra Bhasma, and Loha Bhasma. The above mixture is titrated with kantakari swarasa, dhatura swarasa, and katuki swarasa.
Benefits of Suvarna Vasant Malini Rasa (सुवर्ण मालिनी वसंत) in Leukemia or Blood Cancer Patients
- a) Suvarna Malini Vasant as Rejuvenation in Leukemia or Blood Cancer Patients: Suvarna Malini Vasant helps to promotes vitality, health, and longevity in Leukemia or Blood Cancer Patients. Suvarna Malini Vasant can also be called as Rasayana in Ayurveda.
- b) Suvarna Malini Vasant as Nervine Tonic in Leukemia or Blood Cancer Patients: Suvarna Malini Vasant is a good nervine tonic, and helps to support nervous system and improve cognitive functions in blood cancer patients or leukemia.
- c) Suvarna Malini Vasant boosts Immune System in Leukemia or Blood Cancer Patients: Suvarna Malini Vasant boosts immune system and help leukemia or blood cancer patients to better cope up with the disease.
2) Updansa surya Rasa (उपदंस सूर्य रस) in Leukemia or Blood Cancer Patients
Updansa surya rasa is a arsenical compound mentioned in Ayurveda. Somal or Arsenic Tri-Oxide as mentioned in Ayurveda is titrated with Trifala Kadha, Solanum nigrum, and lemon juice. This titration is given for consecutive 42 days. After 42 days small pills are rolled. It is important to note that Updansa surya Rasa (उपदंस सूर्य रस) is a arsenical compound and should be consumed under strict medical advice.
Benefits of Updansa surya Rasa (उपदंस सूर्य रस) in Leukemia or Blood Cancer Patients
Arsenic Trioxide (Somal) has shown efficacy in various types of cancer but its efficacy is well established in acute promyelocytic leukemia (APL). Updansa surya Rasa (उपदंस सूर्य रस) has a potential is many other hematologic malignancies and solid tumors.
- a) Acute Myeloid Leukemia and Myelodysplastic Syndromes: Updansa Surya Rasa (उपदंस सूर्य रस) has demonstrated efficacy against various subtypes of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS).
- b) Lung Cancer: Updansa Surya Rasa (उपदंस सूर्य रस) has shown promising results in Non-Small Cell Lung Cancer (NSCLC), and its efficacy is even better if it is used in combination with radiotherapy.
- c) Liver Cancer: Updansa Surya Rasa (उपदंस सूर्य रस) can be used in combination or as a single agent in Hepatocellular Carcinoma (HCC).
- d) Breast Cancer: Updansa Surya Rasa (उपदंस सूर्य रस) proves beneficial in breast cancer and its various subtypes.
- e) Prostate Cancer: Updansa Surya Rasa (उपदंस सूर्य रस) proves beneficial in prostate cancer as a single agent or in combination.
Arsenic Trioxide (Somal) or Updansa Surya Rasa (उपदंस सूर्य रस) is beneficial in leukemia or blood cancer through induction of apoptosis, inhibition of cell proliferation, and inhibition of angiogenesis. Updansa Surya Rasa (उपदंस सूर्य रस) facilitate in modulation of cellular signaling and so proves beneficial in leukemia or blood cancer. Updansa Surya Rasa (उपदंस सूर्य रस) also facilitate in induction of differentiation and apoptosis in leukemia or blood cancer patients.
3) Allium sativum or one of its formulation Rasonadi vati or Lasunadi vati in Leukemia or Blood Cancer Patients
Allium sativum (Rasona) has effect on leukemia which is characterized by the abnormal proliferation of white blood cells. Rasona, as mentioned in Ayurveda is of ushna virya and vrishya in nature. As per modern research, Allium sativum (Rasona) has many potential benefits in leukemia and it is elaborated further:
- a) Induction of apoptosis: Allium sativum or one of its formulation Rasonadi vati or Lasunadi vati as mentioned in Ayurveda can induce apoptosis or programmed cell death in leukemia cells or blood cancer cells. It induce apoptosis or programmed cell death in leukemia or blood cancer cells by inhibiting their growth and facilitating destruction of the cancer cells.
- b) Anti-inflammatory Activities: It is a well-known and established fact that chronic inflammation plays important role in the development and proliferation of leukemia or blood cancer. Allium sativum or one of its formulation Rasonadi vati or Lasunadi vati helps to reduce inflammation and so proves beneficial in leukemia or blood cancer.
- c) Immunomodulatory effects: Allium sativum or one of its formulation Rasonadi vati or Lasunadi vati modulate the immune system, and so helps in recognizing and destroying the leukemia or blood cancer cells. Allium sativum or one of its formulation Rasonadi vati or Lasunadi vati helps in boosting natural defenses to combat leukemia or blood cancer.
- d) Anti-Angiogenic effects: Allium sativum or one of its formulation Rasonadi vati or Lasunadi vati possess anti-angiogenic effects thereby potentially limiting the blood supply to the leukemia or blood cancer cells.
- e) Antioxidant effects: Allium sativum or one of its formulation Rasonadi vati or Lasunadi vati neutralize free radicals and reduce oxidative stress. The oxidative stress causes DNA damage and thereby further leads to leukemia or blood cancer.
4) Purgation or Virechana Karma (विरेचन कर्म) in Leukemia or blood cancer patients
Virechana Karma is one of the purification therapies mentioned under Panchakarma in Ayurveda. Virechana Karma mainly focusses on eliminating excessive dustha doshas mainly pitta dosha and toxins from the body. Virechana Karma involves administration of purgative medications to induce controlled and gentle purgation which eventually stops on its own.
Virechana Karma involves poorva karma or preparatory phase in which oleation of the patient is done through medicated ghee which help in liquefying the dustha doshas and transporting the toxins toward gastrointestinal tracts for further elimination through administration of purgative drugs.
Virechana Karma helps in balancing Pitta Dosha and improving digestion of the liver cancer patients. It even enhances metabolism, and promote mental and physical well-being of leukemia or blood cancer patients.
About Team ‘Cancer In Ayurveda’
Team ‘Cancer In Ayurveda’ is a dedicated group of researchers and practitioners who are committed to exploring the potential of Ayurveda in managing cancer. With a holistic approach, Team ‘Cancer In Ayurveda’ aim to combine ancient Ayurvedic wisdom with modern scientific methods to develop safe and effective strategies for supporting and managing cancer patients.
The mission of Team ‘Cancer In Ayurveda’ is to bridge the gap between traditional knowledge and evidence-based medicine, ultimately contributing to improved outcomes and better quality of life for those affected by cancer. Together, they strive to create a brighter future in the fight against cancer, inspired by the age-old principles of Ayurveda.
Need some advice from our experts?
Request a Call Back Today Now!
We will make a single attempt to contact you from a withheld number, usually within 24 hours of your request.
